Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells
Hypoxia commonly exists in solid tumors. In this adverse condition, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated a protective way to make hepatocellular carcinoma cells be resi...
Saved in:
Published in | Autophagy Vol. 5; no. 8; pp. 1131 - 1144 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
16.11.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hypoxia commonly exists in solid tumors. In this adverse condition, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated a protective way to make hepatocellular carcinoma cells be resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agents-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed i.e. chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential. |
---|---|
AbstractList | Hypoxia commonly exists in solid tumors. In this adverse condition, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated a protective way to make hepatocellular carcinoma cells be resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agents-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed i.e. chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential. Hypoxia commonly exists in solid tumors. Under such adverse conditions, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated as a protective way to make hepatocellular carcinoma cells resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agent-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed, i.e., chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential.Hypoxia commonly exists in solid tumors. Under such adverse conditions, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated as a protective way to make hepatocellular carcinoma cells resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agent-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed, i.e., chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential. Hypoxia commonly exists in solid tumors. Under such adverse conditions, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated as a protective way to make hepatocellular carcinoma cells resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agent-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed, i.e., chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential. |
Author | Shen, Feng Song, Jianrui Guo, Xianling Zhao, Xue Gao, Lu Qu, Zengqiang Wu, Mengchao Zhao, Qiudong Sun, Kai Wei, Lixin |
Author_xml | – sequence: 1 givenname: Jianrui surname: Song fullname: Song, Jianrui – sequence: 2 givenname: Zengqiang surname: Qu fullname: Qu, Zengqiang – sequence: 3 givenname: Xianling surname: Guo fullname: Guo, Xianling – sequence: 4 givenname: Qiudong surname: Zhao fullname: Zhao, Qiudong – sequence: 5 givenname: Xue surname: Zhao fullname: Zhao, Xue – sequence: 6 givenname: Lu surname: Gao fullname: Gao, Lu – sequence: 7 givenname: Kai surname: Sun fullname: Sun, Kai – sequence: 8 givenname: Feng surname: Shen fullname: Shen, Feng – sequence: 9 givenname: Mengchao surname: Wu fullname: Wu, Mengchao – sequence: 10 givenname: Lixin surname: Wei fullname: Wei, Lixin email: lixinwei@smmu.edu.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19786832$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1v1DAQhi1URD_gyBXlxinbxE6c5FhVQJEq9UB7xZodj7tGiR1sR7D_HkfbLhICcfKHnndm9Mw5O3HeEWNv62rT1LK-hCX5TbvpN8MwyBfsrG7bpuylaE-Od96dsvMYv1WVkP3AX7HTeuh62Qt-xr7e7Gf_00JpnV6QdLHWm3fwuC_QuxTsdkkUi-SLtKMCdzT5QNHGBA6p8KbY0QzJI43jMkIoEAJa5yco1q_4mr00MEZ683ResIePH-6vb8rbu0-fr69uS2yFSCXpuuFVL2VFvEajkepegyQ-NKQrMAjYEefAq7ZD06DgldGkm22d39RKccHeH-rOwX9fKCY12bhOAI78ElUnsizZtUMm3z2Ry3YireZgJwh79awkA-UBwOBjDGR-I5ValatVkWpVr1blmRd_8GgTJLvaAzv-MyUPqTyhpri1PqKl7PTY7bgIBSFZHOk5ePmf4BfvHq8e7u_WXrM2OdEfEtYZHyb44cOoVYL96IMJeY82KvH3KX8BJ3rC3g |
CitedBy_id | crossref_primary_10_1111_j_1742_4658_2011_08381_x crossref_primary_10_1016_j_canlet_2017_12_013 crossref_primary_10_1007_s12013_015_0558_z crossref_primary_10_1016_j_canlet_2018_01_044 crossref_primary_10_1111_cpr_12411 crossref_primary_10_4028_www_scientific_net_AMR_926_930_1124 crossref_primary_10_3389_fonc_2021_738385 crossref_primary_10_18632_oncotarget_8433 crossref_primary_10_18632_oncotarget_9643 crossref_primary_10_1517_13543784_2014_912274 crossref_primary_10_1007_s00216_018_0996_8 crossref_primary_10_1038_s41388_017_0046_6 crossref_primary_10_1016_j_neo_2024_101015 crossref_primary_10_1016_j_ijpharm_2024_125156 crossref_primary_10_1186_s12863_022_01055_9 crossref_primary_10_3892_ijo_2018_4376 crossref_primary_10_18632_oncotarget_19048 crossref_primary_10_1111_1440_1681_12581 crossref_primary_10_3390_cancers14225685 crossref_primary_10_3390_cells1030597 crossref_primary_10_18632_oncotarget_2189 crossref_primary_10_1186_s10020_018_0033_6 crossref_primary_10_1128_MCB_00740_14 crossref_primary_10_1002_jcb_23274 crossref_primary_10_4161_auto_32229 crossref_primary_10_3892_ol_2017_6449 crossref_primary_10_12659_MSM_889486 crossref_primary_10_1002_jcp_26448 crossref_primary_10_1186_s12943_022_01620_x crossref_primary_10_1016_j_phrs_2012_07_003 crossref_primary_10_1038_onc_2013_552 crossref_primary_10_1097_FJC_0000000000000295 crossref_primary_10_1039_D3NH00061C crossref_primary_10_18632_aging_103027 crossref_primary_10_1371_journal_pone_0065304 crossref_primary_10_3892_ijo_2016_3557 crossref_primary_10_1186_1476_4598_10_12 crossref_primary_10_1016_j_jacbts_2020_04_014 crossref_primary_10_15252_embr_201438850 crossref_primary_10_1016_j_yexcr_2022_113334 crossref_primary_10_1016_j_yexmp_2010_11_011 crossref_primary_10_1038_s41388_018_0348_3 crossref_primary_10_1016_S0929_6646_10_60122_2 crossref_primary_10_18632_aging_202137 crossref_primary_10_1007_s00204_012_0931_2 crossref_primary_10_18632_oncotarget_17202 crossref_primary_10_1038_srep05382 crossref_primary_10_1155_2011_470597 crossref_primary_10_3109_15376516_2012_686534 crossref_primary_10_5507_bp_2015_025 crossref_primary_10_1016_j_jep_2017_07_020 crossref_primary_10_3389_fnut_2019_00148 crossref_primary_10_1371_journal_pone_0179357 crossref_primary_10_1016_j_canlet_2024_216856 crossref_primary_10_1038_s12276_022_00780_6 crossref_primary_10_1038_s41420_020_00315_w crossref_primary_10_1016_j_biopha_2020_111023 crossref_primary_10_1038_s41598_017_09503_8 crossref_primary_10_1016_j_bcp_2011_06_015 crossref_primary_10_1016_j_biocel_2015_02_010 crossref_primary_10_1016_j_yexcr_2022_113105 crossref_primary_10_1016_j_semcancer_2014_06_001 crossref_primary_10_1007_s10549_015_3283_9 crossref_primary_10_1016_j_bbcan_2013_02_003 crossref_primary_10_1038_cddiscovery_2017_68 crossref_primary_10_3892_or_2015_3742 crossref_primary_10_1038_bcj_2014_96 crossref_primary_10_3892_ijo_2015_2885 crossref_primary_10_1038_s41598_022_12519_4 crossref_primary_10_1038_srep12291 crossref_primary_10_1186_s12929_019_0557_2 crossref_primary_10_18632_oncotarget_22890 crossref_primary_10_1016_j_abb_2020_108281 crossref_primary_10_3892_or_2013_2474 crossref_primary_10_1042_BSR20160238 crossref_primary_10_3390_ijms21238991 crossref_primary_10_1016_j_trsl_2017_11_007 crossref_primary_10_1111_febs_12810 crossref_primary_10_1016_j_molonc_2016_08_005 crossref_primary_10_3389_fonc_2018_00226 crossref_primary_10_3389_fonc_2022_1008902 crossref_primary_10_1074_jbc_M109_090530 crossref_primary_10_1158_0008_5472_CAN_11_1094 crossref_primary_10_3390_cancers9100137 crossref_primary_10_3724_SP_J_1008_2011_00238 crossref_primary_10_1016_j_canlet_2014_01_011 crossref_primary_10_1245_s10434_010_1444_y crossref_primary_10_1007_s00280_018_3669_6 crossref_primary_10_1016_j_jbo_2016_03_001 crossref_primary_10_1080_15548627_2015_1034405 crossref_primary_10_3350_cmh_2020_0169 crossref_primary_10_1016_j_tranon_2020_100851 crossref_primary_10_1158_0008_5472_CAN_18_0491 crossref_primary_10_1186_2045_3701_4_49 crossref_primary_10_3109_15376516_2013_843105 crossref_primary_10_1016_j_canlet_2012_03_002 crossref_primary_10_1016_j_bcp_2013_01_022 crossref_primary_10_3892_ijmm_2016_2492 crossref_primary_10_1038_sj_bjc_6605904 crossref_primary_10_1007_s11626_021_00625_y crossref_primary_10_1016_j_canlet_2011_09_034 crossref_primary_10_1038_cddis_2013_308 crossref_primary_10_1016_j_canlet_2020_11_045 crossref_primary_10_1016_j_ctrv_2011_06_010 crossref_primary_10_1158_1078_0432_CCR_12_1542 crossref_primary_10_1186_s12951_022_01385_x crossref_primary_10_18632_oncotarget_20415 crossref_primary_10_18632_oncotarget_26637 crossref_primary_10_1080_15548627_2016_1164357 crossref_primary_10_1186_s13578_020_00494_0 crossref_primary_10_1186_s13046_020_01758_w crossref_primary_10_3892_mmr_2015_4599 crossref_primary_10_1021_acsami_2c18267 crossref_primary_10_1016_j_bmcl_2020_127715 crossref_primary_10_3390_ijms20020300 crossref_primary_10_4254_wjh_v6_i10_752 crossref_primary_10_7717_peerj_14797 crossref_primary_10_4254_wjh_v13_i1_6 crossref_primary_10_1016_j_mrfmmm_2011_07_003 crossref_primary_10_1007_s00109_012_0966_0 crossref_primary_10_1038_cddis_2013_167 crossref_primary_10_1016_j_jep_2023_116633 crossref_primary_10_1148_radiol_2016152099 crossref_primary_10_3389_fphar_2022_968223 crossref_primary_10_3389_fonc_2022_891652 crossref_primary_10_1016_j_heliyon_2024_e29859 crossref_primary_10_1016_j_cellsig_2015_07_009 crossref_primary_10_1186_s12943_017_0734_4 crossref_primary_10_1038_s41392_020_00453_8 crossref_primary_10_3389_fonc_2021_783526 crossref_primary_10_1039_C9NJ05808G crossref_primary_10_1007_s13273_020_00107_4 crossref_primary_10_1016_j_bbrc_2015_02_027 crossref_primary_10_1016_j_lfs_2020_118722 crossref_primary_10_1186_2045_3701_4_22 crossref_primary_10_1002_jcb_26912 crossref_primary_10_1002_pros_21337 crossref_primary_10_1016_j_exphem_2014_06_005 crossref_primary_10_1080_15548627_2019_1630223 crossref_primary_10_1016_j_cell_2017_07_008 crossref_primary_10_1038_onc_2016_521 |
ContentType | Journal Article |
Copyright | Copyright © 2009 Landes Bioscience 2009 |
Copyright_xml | – notice: Copyright © 2009 Landes Bioscience 2009 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.4161/auto.5.8.9996 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1554-8635 |
EndPage | 1144 |
ExternalDocumentID | 19786832 10_4161_auto_5_8_9996 10909996 |
Genre | Research Article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0BK 0R~ 23N 30N 53G 5GY AAJMT AALDU AAMIU AAPUL AAQRR ABCCY ABFIM ABFMO ABJNI ABLIJ ABPAQ ABPEM ABTAI ABXUL ABXYU ACGFS ACTIO ADBBV ADCVX ADGTB ADHGD ADYSH AEISY AENEX AEYOC AFRVT AGDLA AHDZW AIJEM AIYEW AKBVH AKOOK ALMA_UNASSIGNED_HOLDINGS ALQZU AMPGV AOIJS AQRUH AVBZW AWYRJ BAWUL BLEHA C1A CCCUG DGEBU DIK DKSSO E3Z EBS EJD F5P GTTXZ H13 HYE KYCEM M4Z O9- OK1 P2P RNANH ROSJB RPM RTWRZ SNACF TBQAZ TDBHL TEI TFL TFT TFW TQWBC TR2 TTHFI TUROJ ZGOLN - 0R AAAVI ABJVF ABQHQ AEGYZ AFOLD AHDLD AIRXU FUNRP FVPDL V1K ZA5 AAGDL AAHIA AAYXX CITATION 4.4 AAGME ACDHJ ACZPZ ADOPC AURDB BFWEY CGR CUY CVF CWRZV ECM EIF EMOBN IPNFZ LJTGL NPM PCLFJ RIG TASJS 7X8 |
ID | FETCH-LOGICAL-c533t-ed14208660e21cfdce18da6e294ed0afcac7e22a2057cf4c320fded4b157ce563 |
ISSN | 1554-8627 1554-8635 |
IngestDate | Tue Aug 05 09:14:19 EDT 2025 Mon Jul 21 05:50:19 EDT 2025 Tue Jul 01 01:44:04 EDT 2025 Thu Apr 24 22:53:40 EDT 2025 Fri Jan 15 03:37:17 EST 2021 Tue May 21 11:32:54 EDT 2019 Tue May 20 10:46:39 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c533t-ed14208660e21cfdce18da6e294ed0afcac7e22a2057cf4c320fded4b157ce563 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.tandfonline.com/doi/pdf/10.4161/auto.5.8.9996?needAccess=true |
PMID | 19786832 |
PQID | 734166759 |
PQPubID | 23479 |
PageCount | 14 |
ParticipantIDs | pubmed_primary_19786832 landesbioscience_primary_autophagy_article_9996 informaworld_taylorfrancis_310_4161_auto_5_8_9996 proquest_miscellaneous_734166759 crossref_primary_10_4161_auto_5_8_9996 crossref_citationtrail_10_4161_auto_5_8_9996 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-11-16 |
PublicationDateYYYYMMDD | 2009-11-16 |
PublicationDate_xml | – month: 11 year: 2009 text: 2009-11-16 day: 16 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Autophagy |
PublicationTitleAlternate | Autophagy |
PublicationYear | 2009 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
SSID | ssj0036892 |
Score | 2.36003 |
Snippet | Hypoxia commonly exists in solid tumors. In this adverse condition, adaptive responses including autophagy are usually provoked to promote cell survival. In... Hypoxia commonly exists in solid tumors. Under such adverse conditions, adaptive responses including autophagy are usually provoked to promote cell survival.... |
SourceID | proquest pubmed crossref landesbioscience informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1131 |
SubjectTerms | Adenine - analogs & derivatives Adenine - pharmacology Apoptosis - drug effects Apoptosis Regulatory Proteins - metabolism Autophagy - drug effects Beclin-1 Binding Biology Bioscience Calcium Cancer Carcinoma, Hepatocellular - pathology Cell Cell Cycle - drug effects Cell Hypoxia - drug effects Cisplatin - pharmacology Cycle Drug Resistance, Neoplasm - drug effects Drug Screening Assays, Antitumor Gene Knockdown Techniques Green Fluorescent Proteins - metabolism Hep G2 Cells Humans Landes Liver Neoplasms - pathology Membrane Proteins - metabolism Organogenesis Proteins |
Title | Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells |
URI | https://www.tandfonline.com/doi/abs/10.4161/auto.5.8.9996 http://www.landesbioscience.com/journals/autophagy/article/9996/ https://www.ncbi.nlm.nih.gov/pubmed/19786832 https://www.proquest.com/docview/734166759 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ri9NAEF_0RNAP5_O0vtgPIoKml0ezTT4eckeRs4fQQvGDy2Z3UgtnUq8JWP96Zzavtlzx8SW0082m2fnt7Mzs7Axjr700CAMtjDNE6wMNlEg7KqFEyMKNYuVCHBgyFD-NxWg6-DgLZ10xTnu6pEj6-te150r-h6tIQ77SKdl_4GzbKRLwM_IXr8hhvP4Vj0frZf5zoRy0q0vax1clpQlQ83UVgU6lrKoMDqRdIncoqHZFCiPNZqslLtHmJt-9DUbVVFcoy7-rd0RabeqtJ03PrUemCeWlhEHlovOf2t0OyOY_8Id5G91TWo_sDGmXi4785Zuy9M-L0uQ1ufFAxHQUrzog2QhNZHMkqrQjfbiGVkvacANQ0YbU9LxqJdgV52R80VqFr9gP-1GfjLNu3Wr26scX8mx6fi4np7PJTXbLR3uBBF7gjpslORCRrY7d_qkq2Sp1f7zV-ZZyspW69i67R5GmtGlXJxmF_TaJ1U0m99lhbVTwkwohD9gNyB6y21WZ0fUj9nUHJ7zFCd_ACS9yjjjhOzjhecq3ccJbnHCLk8dsenY6-TBy6roajkblvnDAeBRUIYQLvqdTo8GLjBLgxwMwrkq10kPwfeWjLq_TgQ58NzVgBomH3yEUwRE7yPIMnjIOAHoYCcrypwcQi8QkHgQx1ZZ3TQiix943Ayp1nXSeap9cSjQ-afwlvbEMZSRp_HvsTdt8WWVb2dfQ2-SOLKx7K61q0chgzz1vd1nYPoQmDYqOC2q7NGmPHe9t2rJI1vO-7pw3YJAooGn4VQZ5uZJD1BMFmuVxjz2pQNK9Woxjh0vqsz_f_Jzd6abeC3ZQXJXwEtXhInllof4b2nbA3g |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JbtRAEC2FIAQcCDvD2gdAHLDjtW0fOCAgmpBkOJBIOaVpd5eTCLBH2CMYPolf4aeo8jKQoLkg5cDRVnvp6lpeucuvAB77RRiHRlonoeyDEpTUODpnImTppZn2MAstJ4o7Eznei97ux_sr8GP4F4bLKjmHLjqiiNZXs3Hzx2i2cMbj63rWVG7spi6j9b6gcgvnXyldq19svqa1fRIEG292X42dvqOAYwjWNA5an7eTpfQw8E1hDfqp1RKDLELr6cJok2AQ6IBQjCkiEwZeYdFGuU_HGMuQ7nsOzseZTNimQm8yeP1Qpm0DZg7PDmUJScfn-ffrnoh_J9hRL8MaFzPyvlDPY4nLYW8b_jbW4OcguK7q5aM7a3LXfD_FKfl_SPYqXOlRuHjZmc01WMHyOlzo-nLOb8DBeD6tvh1r57i0pPpW8AtPj_ThXLSl_dwjDGvRVILgsyC152rlmpE4SVNUhTiiIN9UvCnCVb7CcMOmsvqsBZ-qb8LemUzuFqyWVYl3QCCiSVLJtHgmwkzmNvcxzLgZu2djlCN4PqiHMj1LOzcL-aQoW-MlUjxjFatU8RKN4Oli-LSjJ1k20P9T11TTfg8quuYtKlxyzbPTCrl4yPuqPCQP-o7HTm0xgvWlQxdLpHpn2N9cDKqtyKOx-HWJ1axWCQErSXlsNoLbncr_nlpGsqMYdPcfZvMILo53d7bV9uZk6x5cancFuZxT3ofV5ssMHxC4bPKHrVUL-HDWyv4LTlKQWw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIhAcKG-Wpw-AOJA0Tyc5cECU1ZbCggSVesI49qStgGRFsoLlH_FX-FXM5LHQor0g9cAxkePE488z38TjGYD7fhHGoZHWScj7IAclNY7OORGy9NJMe5iFlh3FV1M52Y1e7MV7a_BjOAvDYZXsQxddoohWV_PintmCFzjT8U09byo3dlOXyXofT7mDi6_krdVPtrdoah8Ewfj5u2cTpy8o4BhiNY2D1ufdZCk9DHxTWIN-arXEIIvQerow2iQYBDogEmOKyISBV1i0Ue7TNcYypH5PwWnJBzr5tIg3HZR-KNO2_jJbZ4echKRL5_n35x4xf0eSo56HDY5l5G2hPo0lrma9rfUbb8DPQW5d0MtHd97krvl-LKXkfyHYi3Ch5-DiabdoLsEalpfhTFeVc3EF3k8Ws-rboXYOS0vAt4I_eHag9xeiDeznCmFYi6YSRJ4FgZ5jlWvm4SRMURXigEx8U_GWCMf4CsPlmsrqsxZ8q74KuycyuGuwXlYl3gCBiCZJJSfFMxFmMre5j2HGpdg9G6McweMBHcr0Odq5VMgnRb4aT5HiEatYpYqnaAQPl81nXXKSVQ39P6GmmvZvUNGVblHhimceHcfj8iVvq3Kf9OdrbksAGsHmyqbLKVK9Kuw7FwOyFekzFr8usZrXKiFaJcmLzUZwvUP876FlJDuyQDf_YTT34OybrbF6uT3duQXn2i1BjuWUt2G9-TLHO8Qsm_xuu6YFfDhprP8C95mO_w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia-induced+autophagy+contributes+to+the+chemoresistance+of+hepatocellular+carcinoma+cells&rft.jtitle=Autophagy&rft.au=Song%2C+Jianrui&rft.au=Qu%2C+Zengqiang&rft.au=Guo%2C+Xianling&rft.au=Zhao%2C+Qiudong&rft.date=2009-11-16&rft.issn=1554-8635&rft.eissn=1554-8635&rft.volume=5&rft.issue=8&rft.spage=1131&rft_id=info:doi/10.4161%2Fauto.5.8.9996&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1554-8627&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1554-8627&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1554-8627&client=summon |